Novarad HEI Logo 2017 Red Swirl Black Te

CORPORATE HEADQUARTERS

752 East 1180 South, Suite 200

American Fork, Utah  84003

(877) 668-2723 phone

UNITED KINGDOM

12 Kingsbury Trading Estate Church Lane

Kingsbury London United Kingdom

NW9 8AU

+44 (0) 208 205 9500 phone

+44 (0) 208 205 0585 fax

LATIN AMERICA

2 Calle A 6-28 zona 10 Edificio Verona, Oficina 502
Edificio Verona, Oficina 502
Guatemala, Guatemala

ASIA - PACIFIC

407 Prestige Tower F. Ortiga Jr. Road
Ortigas Center, Pasig City Philippines, 1605
Phone: +632.661.6161
Fax: +632.661.4334

© 2020 Novarad®

The Washington Times | 'Cutting-edge science': OCD drug designed by artificial intelligence


Two pharmaceutical companies have embarked on a brave new world, having begun human testing for the first time on a drug treatment for obsessive-compulsive disorder designed by artificial intelligence.


“Different properties of molecules will create different side effects, and so it’s a very intriguing idea to use AI, a computer, to help predict,” said Dr. Wendell Gibby, a radiologist in Utah and CEO of Novarad, a health care technology and imaging company. “AI is a very powerful technique that’s being used across many fields of medicine, especially in radiology.”


Read the full article in The Washington Times.



Novarad Health Care Technology Innovation